Comparison of Volulyte® versus Tetraspan® in patients undergoing cardiopulmonary bypass.

Comparative study of two balanced hydroxyethyl starch solutions in patients undergoing cardiopulmonary bypass during valvular cardiac surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21191

Enrollment

Registered

2011-11-10

Start date

2011-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiopulmonary bypass, balanced hydroxyethyl starch, cardiac surgery

Interventions

Administration of Tetraspan versus Volulyte in cardiopulmonary bypass priming and as resuscitation fluid during valvular cardiac surgery.

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients undergoing valvular cardiac surgery with cardiopulmonary bypass.

Exclusion criteria

Exclusion criteria: Patients with preoperative renal failure, redo or urgent operations, IABP.

Design outcomes

Primary

Measure	Time frame
1. Coagulation status; 2. Colloid osmotic pressure; 3. Acid/base balance and ion balance.	—

Secondary

Measure	Time frame
1. Blood loss; 2. Morbidity.	—

Contacts

Public ContactVeerle Mossevelde, van

Laarbeeklaan 101

veerle.vanmossevelde@uzbrussel.be+32 (0)2 4763134

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)